Shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the four research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. The average […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Free Report)’s stock price dropped 2.2% during mid-day trading on Monday . The company traded as low as $3.00 and last traded at $3.06. Approximately 180,163 shares were traded during trading, a decline of 83% from the average daily volume of 1,057,536 shares. The stock had previously closed at $3.13. […]
By Denny Jacob Amneal Pharmaceuticals on Monday said it received a request from the Food and Drug Administration for additional information regarding an.
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating)’s share price was up 6.6% on Tuesday . The company traded as high as $2.42 and last traded at $2.42. Approximately 654,116 shares changed hands during mid-day trading, a decline of 33% from the average daily volume of 982,323 shares. The stock had previously closed at $2.27. Wall […]
Shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) have received an average rating of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price […]